A federal judge blocked parts of HHS's vaccine policy changes, siding with medical groups against Robert F. Kennedy Jr.'s agenda.
Add Yahoo as a preferred source to see more of our stories on Google. Food and Drug Administration (FDA) Commissioner Marty Makary on Friday announced that the agency’s top regulator Vinay Prasad will ...
Hosted on MSN
Top FDA regulator to leave the agency
Food and Drug Administration (FDA) Commissioner Marty Makary on Friday announced that the agency’s top regulator Vinay Prasad will depart next month. “A year ago, Dr. Prasad came to the FDA to ...
In a wide-ranging conversation on the podcast Inside Indian America, the Shah Capital founder reflects on markets, geopolitics, AI, and lessons from a three-decade career.
Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Immatics today and set a price target of $17.00. Stranahan covers the Healthcare sector, focusing on stocks such as Novavax ...
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users ...
The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean ...
March 19 (Reuters) - Novo Nordisk said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its ...
Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) in advanced-stage classical Hodgkin lymphoma. CA209-8UT randomized 994 ...
The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results